Differential response of triple‐negative breast cancer to a docetaxel and carboplatin‐based neoadjuvant treatment

Helena R. Chang, John Glaspy, Mary Ann Allison, Frederic C. Kass, Robert Elashoff, Debra U. Chung, Jeffrey Gornbein

Open source

DOI
10.1002/cncr.25309
Published
2010-06-14
Container
Cancer
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/cncr.25309,
  title = {Differential response of triple‐negative breast cancer to a docetaxel and carboplatin‐based neoadjuvant treatment},
  author = {Helena R. Chang and John Glaspy and Mary Ann Allison and Frederic C. Kass and Robert Elashoff and Debra U. Chung and Jeffrey Gornbein},
  year = {2010},
  journal = {Cancer},
  doi = {10.1002/cncr.25309},
  url = {https://doi.org/10.1002/cncr.25309}
}

RIS

TY  - JOUR
TI  - Differential response of triple‐negative breast cancer to a docetaxel and carboplatin‐based neoadjuvant treatment
AU  - Helena R. Chang
AU  - John Glaspy
AU  - Mary Ann Allison
AU  - Frederic C. Kass
AU  - Robert Elashoff
AU  - Debra U. Chung
AU  - Jeffrey Gornbein
PY  - 2010
JO  - Cancer
DO  - 10.1002/cncr.25309
UR  - https://doi.org/10.1002/cncr.25309
ER  - 

APA

Chang, H. R., Glaspy, J., Allison, M. A., Kass, F. C., Elashoff, R., Chung, D. U., & Gornbein, J. (2010). Differential response of triple‐negative breast cancer to a docetaxel and carboplatin‐based neoadjuvant treatment. Cancer. https://doi.org/10.1002/cncr.25309

Source records